Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Just months before Rob Bilott made partner at Taft Stettinius & Hollister, he received a call on his direct line from a cattle farmer. The farmer, Wilbur Tennant of Parkersburg, W.Va., said that his cows were dying left and right. He believed that the DuPont chemical company, which until recently operated a site in Parkersburg that is more than 35 times the size of the Pentagon, was responsible. Tennant had tried to seek help locally, he said, but DuPont just about owned the entire town. He had been spurned not only by Parkersburg’s lawyers but also by its politicians, journalists, doctors and veterinarians. Bilott decided right away to take the Tennant case, [and] filed a federal suit against DuPont in the summer of 1999. Dozens of boxes containing thousands of unorganized documents began to arrive at Taft’s headquarters: private internal correspondence, medical and health reports and confidential studies conducted by DuPont scientists. The story that Bilott began to see ... was astounding in its breadth, specificity and sheer brazenness. DuPont was nothing like the [other chemical] corporations he had represented at Taft. "DuPont had for decades been actively trying to conceal their actions. They knew this stuff was harmful, and they put it in the water anyway. These were bad facts." He had seen what the ... tainted drinking water had done to [the Tennants'] cattle. What was it doing to the tens of thousands of people in the areas around Parkersburg who drank it daily from their taps?

Note: Read the complete, detailed account of the lawsuit that exposed DuPont's massively harmful criminality at the link above. Read more about the thousands of people DuPont knowingly poisoned in this article. For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

Alex Hummell says few dentists seem worried enough about invisible, odorless mercury to take the kinds of precautions needed to prevent everyday exposures. As the head of a ... firm that sells sophisticated equipment to gauge airborne levels of highly toxic mercury at industrial sites worldwide, Hummell has watched manufacturers of all sorts put their employees through strict training programs in which they don special equipment to avoid even tiny exposures. Then he walks into dental clinics and is dumbfounded. On numerous occasions, he said, he has detected mercury levels in dental offices that were two to three times the average workday exposure limit of 100 micrograms per cubic meter set by the Occupational Safety and Health Administration, but patients and the staff were wearing little or no protective equipment. “I’ve seen in dental offices what would make these other offices have to shut down,” said Hummell. “They would be closing their doors and getting respirators on.” Instead, he said, “there are kids running around everywhere. It’s nuts. It’s the exact same toxin, and it’s being treated totally differently.” Several years ago, Hummell said, he set up a booth at a regional dental conference in Denver to demonstrate how his equipment could pick up rising mercury levels with a mere gentle brushing of a filling in an old tooth.

Note: For more on risks of mercury in fillings, see this mercola.com article. For more, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

About 8 percent of Americans experience PTSD; for veterans, that number is 30 percent. Treatment is notoriously difficult, but people could find relief in an unusual form: psychedelic drugs. MDMA - found in molly and ecstasy - earned a bad rap in the 1990s as ravers’ drug of choice. But psychotherapists are coming to value the way it increases empathy while decreasing fear and defensiveness. “MDMA gives people the ability to revisit an event that’s still painful without being overwhelmed,” says psychiatrist Michael Mithoefer. Following a recent MDMA trial, 83 percent of his treatment-resistant participants no longer showed symptoms of PTSD. In one study, Mithoefer worked with a New York City firefighter post-9/11. The subject had tried treatment before. While undergoing a popular method that uses eye movement to reprocess a trauma, he’d been so overcome that he ripped a sink off the wall. MDMA, however, worked. “It wasn’t easy for him,” Mithoefer says. “But our sink is still attached.” MDMA isn’t a one-trick pony either; it can treat end-of-life anxiety and alcoholism, and it’s not addictive. “We’re talking about the rise of a whole field of medicine,” says Rick Doblin, founder of the nonprofit Multidisciplinary Association for Psychedelic Studies, which is running a handful of MDMA trials, including Mithoefer’s. Doblin thinks the FDA will greenlight the drug for mainstream use by 2021.

Note: While the war on drugs has been called a "trillion dollar failure", the healing potentials of mind altering drugs are starting to be investigated more openly.

Dr. Nav Persaud, a family doctor in Toronto, asked and received thousands of pages of documents from Health Canada, and what he saw made him question the effectiveness of a popular morning sickness drug. But he can't talk about it, because Health Canada forced him to sign a confidentiality agreement, and threatened him with legal action if he makes the data public. Matthew Herder, [a] health law associate professor ... is calling on other doctors, researchers and journalists to bombard Ottawa with their own demands for drug industry data, using [a] new legislative lever written into ... the Protecting Canadians from Unsafe Drugs Act, which was passed late last year. Today, in the Canadian Medical Association Journal, Herder is urging Canadians to use the clause [to request] data that has long been protected by a wall of bureaucratic and corporate secrecy. The European Medicines Agency has started publishing all of the clinical reports submitted as part of drug marketing authorization applications - the same material Health Canada refuses to disclose. Almost half of the drug trials remain secret. [In the US], one group looked at 12 antidepressants, comparing the published studies with the internal FDA assessments. 94 per cent of the published studies were positive, compared to 51 per cent when they included all of the studies assessed by the FDA. The authors concluded that without seeing all the data, drug effectiveness can be exaggerated, leading doctors and patients to assume the medications work better than they do.

Note: For more along these lines, see concise summaries of deeply revealing news articles about government corruption and big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

A judge ruled on Thursday that the New York City health department could not require young children to be vaccinated for the flu to attend city-licensed preschools and day care centers, striking down one of the more ambitious public health initiatives of the Bloomberg administration. Justice Manuel J. Mendez ... said the city could not add influenza to the list of diseases requiring immunization without action by the State Legislature. The mandate ... was scheduled to take effect in January. It required children between the ages of 6 months and 59 months to be vaccinated by shot or mist. The measure was approved unanimously by the Board of Health. But the proposal soon met fierce opposition, with many parents resisting and saying that their doctors told them the vaccine was not needed. The court ruling did not delve into the debate about vaccines. Michelle Carroll, 44, one of the plaintiffs in the suit and the mother of a 4-year-old girl, said the ruling was a victory for parents. “It’s important for people to remember that vaccines are drugs and just like any other drug, not every vaccine is going to be right for every single child,” Ms. Carroll said. The ruling was important, she said, because it left “the decision about whether or not to vaccinate our smallest, youngest, most vulnerable citizens” with pediatricians and parents.

Note: According to this NPR article, last year "the vaccine was only about 13 percent effective against the main strain." Could it be that we are being tricked into believing these vaccines a much more effective than they really are? Remember that big Pharma makes big profits from vaccines. For more, see this mercola.com article. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

With cellphone batteries typically lasting about a day because battery technology hasn’t kept pace with the ever-increasing power of many feature-rich phones, reaching for a cumbersome charger is a necessary chore. A new standard for wireless charging that’s becoming increasingly prevalent in furniture, cars, and some airport lounges and hotels wants to change that. The concept behind the chargers is straightforward - a base plugged into an electrical outlet emits a constantly-varying magnetic field, which causes a receiver in the device to vibrate, powering the battery and allowing it to charge. So far, more than 200 companies - including Microsoft, Samsung, LG Electronics, Verizon, Sanyo, and Phillips - have agreed to use a standard for the chargers called Qi. The market for wireless chargers has been growing steadily, with companies shipping 55 million devices that charged wirelessly in 2014, which grew to an expected 160 million this year, or $1.7 billion in sales. Since the technology is relatively new, there are some catches - Apple’s iPhone doesn’t natively support wireless charging, for example. Carmakers are taking notice of the technology, with Toyota offering wireless charging in its popular Camry and Toyota models and in Lexus cars, while BMW and Audi have begun offering it in some vehicles. Wireless charging continues to be adopted for use with more devices at home, at work, and in the car.

Note: The wireless products industry funds studies that downplay health risks associated with wireless technologies.

Abdel Gawad Ellabbad knows exactly how he was infected with hepatitis C. As a schoolboy in this Nile Delta rice-farming village, his class marched to the local clinic every month for injections against schistosomiasis, a parasitic disease spread by water snails. Six million Egyptians were infected with hepatitis C by unsterile needles during the country’s decades-long fight against schistosomiasis. The virus spread insidiously; today, at least 10 percent of Egyptians, nearly nine million people, are chronically infected, the highest rate in the world. But a grand experiment unfolding across the country may change all that. Pharmaceutical companies are testing ... a complicated deal to sell hepatitis drugs at a fraction of their usual cost. If [successful] the arrangement in Egypt may serve as a blueprint not just for curing hepatitis around the world, but also for providing other cutting-edge medicines to citizens in poor countries who could never afford them. The experiment here is about a year old and, while still fragile, appears to be headed for success. Mr. Ellabbad, for one, was finally cured of hepatitis this spring. An air-conditioning repairman, he took a three-month regimen that included sofosbuvir, first of the new generation of miracle drugs. The pills would have cost more than $84,000 in the United States. He got them free from the Egyptian government, which paid about $900. “Before, I felt like I was dying,” he said. “Now I feel like I’ve never felt before. Like I’m 35 again.”

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Women who took antidepressants in the last six months of pregnancy were 87% more likely to have a child later diagnosed with autism. Doctors saw no increase in autism rates in women who took medication for depression in the first three months of pregnancy, according to [a new] study, published online Monday in JAMA Pediatrics. In the U.S., about 2.2% of children ages 3 to 17 - about one in 45 - have autism, according to the Center for Disease Control and Prevention's National Health Interview Survey, conducted in 2014. Women who took a specific type of antidepressants, called selective serotonin re-uptake inhibitors, or SSRIs, had more than double the risk of having a child with autism. Women who took more than one medication for depression ... were four times as likely to have a child with autism. The new study is ... part of a growing body of research that suggests that the events that cause autism largely occur before birth. Studies have found that children are at higher risk for autism, for example, if they are born early or very small. Children are also at higher risk if they are in medical distress during delivery; if they have older mothers or fathers; or if they are born less than a year after an older sibling.

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

A panel of scientists is disputing a World Health Organization report published earlier this year that concluded glyphosate, the world's most widely used weed killer and main ingredient in Monsanto Co's Roundup herbicide, is probably carcinogenic to humans. The 16-member panel, assembled by Intertek Scientific & Regulatory Consultancy, will present its findings to the annual meeting of the Society for Risk Analysis on Monday, aiming to publish the study at a later date after peer review. Monsanto paid Intertek for the panel's work. Concerns about glyphosate on food have been a hot topic of debate in the United States recently and contributed to the passage in Vermont last year of the country's first mandatory labeling law for foods that are genetically modified. Critics say that industry-linked scientists are downplaying the risk to human health and trying to discredit the IARC report by casting doubt on some of the scientific studies that it reviewed. Ten of the 16 scientists on the Intertek panel have been consultants for Monsanto in the past and two others are former Monsanto employees.

Note: Read an informative article titled "Monsanto Charged With Crimes Against Humanity" on mercola.com. Read how the EPA used industry studies while ignoring independent studies to declare Roundup safe. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

The new movie Consumed tackles the controversial world of Genetically Modified Organisms (GMOs) in unprecedented fashion, offering insight into their risks. Its message could not be more timely in the wake of the recent news that the Food and Drug Administration has approved the first genetically engineered salmon for human consumption. The fish, like all genetically engineered ingredients in this country, will not be labeled, leaving American consumers in the dark. Like many food and environmental safety activists around the world, Im outraged. The biotech industry and the FDA have hijacked not only our basic rights as consumers, but also our fundamental human rights in the face of corporate monopolization of our food supply. They are jeopardizing our health and the environment more than ever before. In detailed comments submitted to the FDA, Michael Hansen, senior scientist at Consumers Union, argues the FDA review process was based on sloppy science and the genetically engineered salmon could pose many risks. Because FDAs assessment is inadequate, we are particularly concerned that this salmon may pose an increased risk of severe, even life-threatening allergic reactions, he writes. The majority of Americans ... believe they have a fundamental right to know what is in their food. A 2013 New York Times poll found that 93% of Americans want GMOs to be labeled. More than 60 countries label GMOs, and in some cases even ban them, but the U.S. still does not.

Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

In approving genetically engineered salmon as safe to eat and safe for the environment, the Food and Drug Administration rejected petitions from environmental and food safety groups asking that companies selling this salmon be required to label it as genetically engineered. Congress should overturn that decision. The salmon, made by AquaBounty Technologies of Maynard, Mass., has genes inserted that allow it to grow to market size twice as fast as wild salmon. At least one consumer group has announced plans to sue the F.D.A. to overturn its approval of the engineered salmon. Some leading grocery chains, responding to consumer concerns, have said they won’t sell the genetically engineered salmon. The F.D.A. said there is no reason to mandate labeling because there is no material difference between engineered and natural fish. But the value of that information should be left to consumers to decide. Vermont enacted a law last year that will require labeling of genetically engineered foods starting next July unless a suit filed in June 2014 by four industry trade groups derails it. Other states with strong consumer movements may try to follow. The House passed a bill on July 23, 2015, that would pre-empt states from requiring such labeling, and industry groups are pressing the Senate to attach similar language as a rider to an omnibus spending bill. The Senate should rebuff that tactic and allow states to adopt mandatory labeling laws if they wish.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Dow AgroSciences, which sells seeds and pesticides to farmers, made contradictory claims to different parts of the U.S. government about its latest herbicide. The Environmental Protection Agency just found out, and now wants to cancel Dow's legal right to sell the product. The herbicide, which the company calls Enlist Duo, is a mixture of two chemicals: glyphosate (also known as Roundup) and 2,4-D. It's Dow's answer to the growing problem of weeds that are resistant to glyphosate, which has become the weed-killing weapon of choice for farmers across the country. The new formulation is intended to work hand-in-hand with a new generation of corn and soybean seeds that are genetically engineered to tolerate sprays of both herbicides. When Dow applied for permission to sell Enlist Duo in 2011, it told the EPA that this mixture of glyphosate and 2,4-D is no more toxic than the two chemicals are, if considered separately. The EPA ... approved the new herbicide just over a year ago, [yet later] discovered that Dow had been telling the U.S. Patent and Trademark Office a different story. Dow's patent application for Enlist Duo claims that this mixture of chemicals does, in fact, offer farmers something new: "synergistic herbicidal weed control." Last month, the EPA asked Dow to explain these synergistic effects. On Nov. 9, the company responded with what the EPA calls "extensive information." The EPA, after taking a look at the new information, decided to ask the court for a chance to reverse its approval of Enlist Duo.

Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." For more along these lines, see concise summaries of deeply revealing news articles about the corruption of science and the controversy surrounding GMOs.

The world’s biggest animal “cloning factory” is due to open in China, producing one million calves a year, sniffer dogs and even genetic copies of the family pet. The center may cause alarm in Europe, where the cloning of animals for farming was banned in September due to animal welfare considerations. But Xu Xiaochun, chairman of Chinese biotechnology company BoyaLife that is backing the facility, dismissed such concerns. Interest in agricultural biotechnology has been rapidly increasing in China, where [beef prices] are said to have tripled from 2000 to 2013. Mr Xu said his new facility will clone racehorses and a handful of dogs for people with “emotional ties” to their pets, but its main focus was producing cattle. However, he appeared to be more excited about its ability to churn out sniffer dogs. “The dog has to be smart and obedient, strong, sensitive," he said. The factory, which will include a 15,000 square metre laboratory, an animal centre, a gene bank and an exhibition hall ... is due to open in the first half of next year. BoyaLife will operate the facility with its South Korean partner, Sooam Biotech, that runs a centre that can clone dogs for customers willing to pay $100,000 (Ł66,000), and has already produced more than 550 puppies. The new facility will initially produce 100,000 cattle embryos a year, eventually increasing to one million.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Consumer advocates, environmental groups, fishermen and retailers reacted strongly to the federal government’s announcement Thursday approving genetically modified salmon for consumer use. The landmark approval - the first genetically engineered food animal endorsed for sale in the United States - has sparked a passionate response ... especially because it will not require special labelling. Around 2 million people previously filed public comments against the FDA’s approval of what opponents call “Frankenfish,” and the Center for Food Safety announced Thursday that it would sue the FDA in response. “This sets the bar incredibly low for engineered animals,” said Michael Hansen, senior scientist at Consumers Union. “There were serious problems with the safety assessment.” At least 60 retailers - including chains like Safeway, Target, Whole Foods and Trader Joe’s, as well as local independent grocers like Bi-Rite and Rainbow Community Market - have made a pledge with Friends of the Earth not to sell the salmon when it goes to market. Chief among concerns about the GMO salmon is its potential for causing allergies and its ability to contaminate wild populations. Testing for potential allergens was only done on a very small sample size. The tested fish actually did show a higher allergenicity. Critics are also concerned about the fish’s ability to escape and cause environmental harm.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Americans may not agree on much. But according to polls, more than 90 percent support genetically engineered (GE) food labeling. Despite the industrial food complex spending hundreds of millions on lobbying against labeling, three states have responded to the call from their voters and passed labeling laws. Vermont's laws will require that companies start labeling by July, 2016. This deadline has the agribusiness community scrambling for a way out. The biotech industry, along with its top enabler at the U.S. Department of Agriculture, Secretary Tom Vilsack, is trying to sell the idea that the long derided and poorly utilized QR code is the answer to consumer concerns about GE foods. A QR code ... is similar to a bar code. To use it, a person must have a smartphone device, an internet connection, and a QR code reader downloaded onto his or her phone. Vilsack and now even Presidential nominee Hillary Clinton are promoting QR code information on GE foods as sufficient to rescind the mandatory on package clear and accessible labeling required by the state laws. Substituting clear and accessible on-package labeling with QR codes would be a form of discrimination against the poor, the rural, the elderly and many other groups. We do not want this discriminatory, burdensome and privacy invasive technology to become the norm.

Note: Read more about why the overwhelming majority of Americans believe GMO foods should require labels. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

The American Medical Association on Tuesday called for a ban on direct-to-consumer ads for prescription drugs and implantable medical devices, saying they contribute to rising costs and patients' demands for inappropriate treatment. Delegates at the influential group's policy-making meeting in Atlanta voted to adopt that as official policy as part of an AMA effort to make prescription drugs more affordable. It means AMA will lobby for a ban. "Today's vote in support of an advertising ban reflects concerns among physicians about the negative impact of commercially driven promotions and the role that marketing costs play in fueling escalating drug prices," said Dr. Patrice Harris, an AMA board member. According to data cited in an AMA news release, ad dollars spent by drugmakers have risen to $4.5 billion in the last two years, a 30 percent increase. Other data show prices on prescription drugs have climbed nearly 5 percent this year, Harris said in the news release. She also raised concern that advertising spurs use of newer brand-name drugs when other possibly lower-cost options might be just as good. "Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate." The pharmaceutical industry opposes the AMA's stance.

Note: For more along these lines, see concise summaries of deeply revealing big pharma profiteering news articles from reliable major media sources. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

This season’s flu vaccine is not as effective against the virus as had been previously believed. Health experts had high hopes for this year’s vaccine because of changes to the recipe following last season’s disappointing success rate. Creating the flu vaccine is not an exact science. Health officials from around the world make their best guesses as to what flu strains to prepare for. They must make their recommendations months in advance so vaccine makers will have time to create and distribute the serum. So far this year, the vaccine has been found to be just 18 percent effective for adults against the H3N2 strain, the dominant strain this season. Officials had hoped for 50 to 60 percent effectiveness for this season’s batch.

Note: According to this NPR article, last year "the vaccine was only about 13 percent effective against the main strain." Could it be that we are being tricked into believing these vaccines a much more effective than they really are? For more, see this mercola.com article. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

A potential anti-Alzheimer’s drug tested in mice unexpectedly reduced general symptoms of aging, according to a study led by Salk Institute researchers. The study examined the effects of the drug, J147, in a strain of mice bred to rapidly age and show signs of senescence. It is the second mouse model to show effectiveness. Besides improved cognition compared to controls, the treated mice exhibited better metabolism, reduced blood leakage from microvessels in the brain, and other improvements. Researchers ... published the study Wednesday in the journal Aging. Abrexa Pharmaceuticals, a San Diego company formed to commercialize J147, has licensed the compound from Salk. The drug is to be tested for Alzheimer's, not for anti-aging properties. Derived from a spice in curry, [J147] was developed ... based on the observation that people in India, where curry is widely consumed, rarely get Alzheimer's. The potential drug has been previously tested in Alzheimer's model mice. It was found to have memory-enhancing effects. The new study, showing effectiveness in another strain of mice, lends further credence to J147's usefulness.

Note: For more on J147 see this article in U.S. News & World Report (particularly the video at the bottom of the page) or do a search on J177. Some are claiming that big Pharma won't study this promising drug as it won't make big enough profits for them.

The Environmental Protection Agency concluded in June that there was “no convincing evidence” that glyphosate, the most widely used herbicide in the U.S. and the world, is an endocrine disruptor. The decision was based almost entirely on pesticide industry studies. Most of the studies were sponsored by Monsanto or an industry group called the Joint Glyphosate Task Force. Of the small minority of independently funded studies that the agency considered in determining whether the chemical poses a danger to the endocrine system, three of five found that it did. One, for instance, found that exposure to glyphosate-Roundup “may induce significant adverse effects on the reproductive system of male Wistar rats.” Another concluded that “low and environmentally relevant concentrations of glyphosate possessed estrogenic activity.” And a review of the literature turns up many more peer-reviewed studies finding glyphosate can interfere with hormones. Many of the industry-funded studies contained data that suggested that exposure to glyphosate had serious effects. Yet in each case, sometimes even after animals died, the scientists found reasons to discount the findings — or to simply dismiss them. Having companies fund and perform studies that affect them financially [is] the standard practice at EPA. The International Agency for Research on Cancer labeled glyphosate a probable carcinogen in March.

Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." Monsanto is trying to stop the state of California from listing Glyphosate as carcinogenic. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Two kinds of genetically modified pigs are on their way to becoming ... dinner. But consumers are wary and lack confidence in governments' readiness to regulate this new class of food product. The African swine fever resistant pig has an immune gene that is slightly more like a warthog's. The double-muscle pig has a mutation similar to one produced by normal breeding in a muscly cow breed called the Belgian blue. Lucy Sharratt, co-ordinator for the Canadian Biotechnology Network, said a major reason why consumers are wary is because of the way genetically modified foods are regulated in Canada. Health Canada doesn't do its own testing of the foods, relying instead on data generated by the companies trying to put the foods on the market, which is kept secret. It doesn't disclose what it's assessing. Nor does it consult with farmers or consumers, or require labelling of genetically modified foods after the fact. In the U.S., safety information about genetically modified foods is also kept secret.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.